Thoreau’s investment values Ensemble at $12 billion
OHIO and VIRGINIA, UNITED STATES — Thoreau, a healthcare investment platform backed by Apollo Global Management, has agreed to make a strategic growth investment in Ensemble Health Partners at a valuation of approximately $12 billion.
According to a report from Fierce Healthcare, Thoreau, founded by veteran PE executive Matt Holt, will become Ensemble’s controlling shareholder, with Berkshire Partners, Warburg Pincus, and Bon Secours Mercy Health continuing as active co-investors.
Ensemble manages revenue cycle operations for more than 200 hospitals, overseeing $55 billion in net patient revenue across patient access, coding, denial prevention, and accounts receivable.
Ensemble’s AI road map anchors Thoreau’s $12Bn investment
Ensemble has been named Best in KLAS for end-to-end revenue cycle outsourcing six times — built on embedding certified RCM operators, proprietary AI, and data analytics into health system financial operations.
Thoreau’s rationale centers on Ensemble’s proprietary RCM-native language models — trained on billions in active provider transactions — which power machine-learning workflows for claim analysis and dispute resolution. At $12 billion, Ensemble is now the highest-valued pure-play RCM outsourcing firm in the U.S. market.
“There is tremendous opportunity to reduce the friction in healthcare for providers, patients, and everyone involved, and we want to remain at the forefront of the innovation that makes that possible,” said Judson Ivy, Founder and CEO of Ensemble Health Partners.
Apollo’s healthcare platform adds RCM at operator scale
Thoreau was founded to operate at the intersection of healthcare administration, technology, and services — using Apollo’s capital base to consolidate RCM and healthcare administrative outsourcing at scale.
The deal follows accelerating health system outsourcing of administrative functions — driven by reimbursement pressure, staffing shortages, and AI tools automating coding, prior authorization, and denial workflows.
The deal signals healthcare administration is consolidating around operator-scale RCM providers — not point solutions — and that Thoreau intends to lead that consolidation.
“Ensemble’s relentless focus on customers and operational excellence has been the foundation of the company’s success,” said Sam Spirn, Managing Director at Berkshire Partners.
Managed RCM outsourcing has consolidated around end-to-end operators — Ensemble, Optum, and nThrive among them — competing for health system accounts that collectively represent hundreds of billions in annual patient revenue.
Apollo’s healthcare portfolio spans insurance, pharmacy benefits, and hospital administration — with the Ensemble stake giving it a major anchor position in the hospital revenue cycle outsourcing market.
Berkshire Partners and Warburg Pincus remaining as active co-investors — rather than exiting — signals that both firms see the $12 billion valuation as a growth anchor, not a near-term exit ceiling.
